Aberrant activation of these pathways is common in various cancer types, such as PI3K gene mutations, PTEN inactivation [14,32], and BRAF mutations [33], leading to continuous proliferative and anti-apoptotic signaling. The gene discussed is PTEN; the disease is cancer.